ICMR's AMRSN monitors antimicrobial susceptibility in clinically important bacteria and fungi affecting human health.iamrsn.icmr.org.in
Local resistance patterns help guide empirical treatment, pathogen-specific therapy and antibiotic stewardship in tertiary care hospitals.iamrsn.icmr.org.in
Antimicrobial Resistance Surveillance and Research Network (ICMR AMRSN): quick facts
- Coordinating centre
- ICMR Headquarters, New Delhi
- Network structure
- 6 nodal centres in 4 tertiary care institutions and 16 regional centres
- Pathogen groups
- 6 groups: diarrhoeagenic bacteria, enteric fever pathogens, Enterobacteriaceae causing sepsis, Gram-negative non-fermenters, Gram-positives including MRSA, and fungi
Key facts
| Coordinating centre | ICMR Headquarters, New Delhiiamrsn.icmr.org.in |
|---|---|
| Network structure | 6 nodal centres in 4 tertiary care institutions and 16 regional centresiamrsn.icmr.org.in |
| Pathogen groups | 6 groups: diarrhoeagenic bacteria, enteric fever pathogens, Enterobacteriaceae causing sepsis, Gram-negative non-fermenters, Gram-positives including MRSA, and fungiiamrsn.icmr.org.in |
| Report 2025 sample base | 1,13,008 positive samples from 30 large hospitals and 20,529 from 34 secondary-care hospitals in 2025Indian Express |
| Top bacterium | Escherichia coli, 24.4% of samples from large hospitalsIndian Express |
Key features and how it works
- Hospital network: tertiary care hospitals track trends in the antimicrobial susceptibility profile of clinically important bacteria and fungi, limited to human health.iamrsn.icmr.org.in
- Nodal centres: each of the six pathogen groups has a nodal centre, for example AIIMS New Delhi for enteric fever pathogens, PGIMER Chandigarh for sepsis-causing Enterobacteriaceae and fungal infections, CMC Vellore for diarrhoeagenic bacteria and gram-negative non-fermenters, and JIPMER Puducherry for gram-positives including MRSA.iamrsn.icmr.org.in
- Regional centres: 16 regional labs from tertiary care hospitals send data on a fixed number of isolates for each pathogen group, following ICMR standard operating procedures for bacteriology and mycology.iamrsn.icmr.org.in
- Data system: ICMR runs a real-time web-based online AMR data entry system for collection, storage and analysis. Nodal centres validate data first.iamrsn.icmr.org.in
- Molecular studies: nodal centres exchange organisms for in-depth molecular studies of clonality and transmission of drug-resistant pathogens.iamrsn.icmr.org.in
Static GK
- Indian Council of Medical Research (ICMR): the apex body for biomedical research in India, funded through the Department of Health Research, Ministry of Health and Family Welfare; it was redesignated from the Indian Research Fund Association in 1949.
- The AMRSN portal includes links to AMR ICMR Data, SOPs and Antimicrobial Stewardship Programme (AMSP) pages.iamrsn.icmr.org.in
- Antimicrobial resistance (AMR): microbes evolve protection against antimicrobial drugs; MDR (multidrug-resistant) microbes are called superbugs; the WHO estimated that bacterial AMR directly caused 1.27 million deaths in 2019.
- WHO GLASS: the Global Antimicrobial Resistance and Use Surveillance System, launched on 22 October 2015 as the first global collaborative effort to standardise AMR surveillance.WHO
Comparison
AMRSN vs WHO GLASS
| Basis | ICMR AMRSN | WHO GLASS |
|---|---|---|
| Launch year | 2013 | 22 October 2015 |
| Scope | Hospital-based surveillance of clinically important bacteria and fungi in India | Global standardised collection of AMR and antimicrobial use data, including national systems |
| Implementing body | ICMR, under Department of Health Research | World Health Organization |
| Pathogen focus | 6 pathogen groups aligned with the WHO priority pathogen list (2017) | Common bacterial infections in humans (GLASS-AMR), plus fungi and gonorrhoea modules |
Achievements
- The 2025 report covered hospitals of two levels, large specialised and secondary-care, and for the first time gave separate findings on newborn bloodstream infections.Indian Express
- The network's pathogen groups align with the WHO priority pathogen list released in 2017.iamrsn.icmr.org.in
Challenges
- Resistance is high in the report: only 9% of tested E. coli samples responded to ciprofloxacin, and 91.1% of Acinetobacter baumannii samples were resistant to carbapenems.Indian Express
- Data quality depends on consistent sampling across hospitals, so regional centres must follow the same SOPs.
- Surveillance covers hospital samples only, so resistance in community and animal settings is not captured.
Way forward
- Outcome monitoring: link annual resistance data to changes in prescribing and track whether resistance falls.
- Convergence with antimicrobial stewardship programmes and the One Health approach used by WHO GLASS.WHO
Timeline
17 November 2026
ICMR's AMRSN Annual Report 2025 finds falling antibiotic effectiveness against common hospital bacteria, now extended to secondary-care hospitals for the first time.
Read the story2026
AMRSN Annual Report 2025 released, with the first separate findings on newborn bloodstream infections.Indian Express
2015
The AMR ICMR Data archive lists 2014 data sets and annual reports from 2017 onward.iamrsn.icmr.org.in
2013
ICMR initiates the Antimicrobial Resistance Surveillance and Research Network (AMRSN).iamrsn.icmr.org.in
1949
Indian Research Fund Association redesignated as the Indian Council of Medical Research.
1911
Indian Research Fund Association set up by the British Government of India, the predecessor of ICMR.
Every new story on this subject is added here automatically.
Frequently asked questions
Who runs the AMRSN?
ICMR runs AMRSN, with its coordinating centre at ICMR Headquarters in New Delhi, working with six nodal centres and 16 regional centres.iamrsn.icmr.org.in
Which bacterium was most common in the AMRSN Annual Report 2025?
Escherichia coli was the most common bacterium, at 24.4% of samples from large hospitals.Indian Express
GS paper mapping
- GS-2Health: government policies and interventions for health sector; diseases and their management
- GS-3Science and technology: developments and their applications in health; biotechnology
Sources
Every fact on this page was checked against these pages.

